当前位置:首页 - 行情中心 - 澳洋健康(002172) - 财务分析 - 现金流量表

澳洋健康

(002172)

  

流通市值:32.52亿  总市值:32.54亿
流通股本:7.65亿   总股本:7.66亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金812,109,565.37309,625,785.381,879,837,176.461,482,650,922.95
  收到的税费返还439,253.38---
  收到其他与经营活动有关的现金177,237,242.06171,420,842.63306,828,472.31280,130,429.54
  经营活动现金流入小计989,786,060.81481,046,628.012,186,665,648.771,762,781,352.49
  购买商品、接受劳务支付的现金660,890,477.91367,526,402.441,538,716,255.031,504,338,327.34
  支付给职工以及为职工支付的现金164,737,870.7993,354,636.78319,133,122.48245,256,607.86
  支付的各项税费31,349,142.8217,561,197.754,512,958.6841,730,578.61
  支付其他与经营活动有关的现金187,936,403.81182,545,096.88273,864,660.95200,691,363.19
  经营活动现金流出小计1,044,913,895.33660,987,333.82,186,226,997.141,992,016,877
  经营活动产生的现金流量净额-55,127,834.52-179,940,705.79438,651.63-229,235,524.51
二、投资活动产生的现金流量:
  收回投资收到的现金---0
  处置固定资产、无形资产和其他长期资产收回的现金净额39,12066,697.9627,704.1812,897.34
  处置子公司及其他营业单位收到的现金净额---0
  投资活动现金流入小计39,12066,697.9627,704.1812,897.34
  购建固定资产、无形资产和其他长期资产支付的现金18,595,089.5916,332,745.3428,639,622.5666,563,585.23
  投资支付的现金--10,200,00010,200,000
  取得子公司及其他营业单位支付的现金-0--
  投资活动现金流出小计18,595,089.5916,332,745.3438,839,622.5676,763,585.23
  投资活动产生的现金流量净额-18,555,969.59-16,266,047.38-38,811,918.38-76,750,687.89
三、筹资活动产生的现金流量:
  吸收投资收到的现金---0
  取得借款收到的现金573,556,493.11537,175,829.861,091,831,659.51,189,499,562.62
  收到其他与筹资活动有关的现金128,722,000128,232,070.75244,000,000207,409,671.74
  筹资活动现金流入小计702,278,493.11665,407,900.611,335,831,659.51,396,909,234.36
  偿还债务支付的现金528,744,595.08423,700,671.81,204,074,220.571,140,896,871.44
  分配股利、利润或偿付利息支付的现金15,650,514.045,934,078.5533,554,127.6128,439,170.82
  其中:子公司支付给少数股东的股利、利润1,125,000-900,000900,000
  支付其他与筹资活动有关的现金123,930,978.8979,290,097.07147,749,040.32118,000,441.08
  筹资活动现金流出小计668,326,088.01508,924,847.421,385,377,388.51,287,336,483.34
  筹资活动产生的现金流量净额33,952,405.1156,483,053.19-49,545,729109,572,751.02
四、汇率变动对现金及现金等价物的影响-1,313.63-449.4814,517.11-10,342.21
五、现金及现金等价物净增加额-39,732,712.64-39,724,149.46-87,904,478.64-196,423,803.59
  加:期初现金及现金等价物余额266,066,794.14266,065,780.6353,971,272.78353,971,272.78
  期末现金及现金等价物余额226,334,081.5226,341,631.14266,066,794.14157,547,469.19
补充资料:
  净利润31,984,041.57-41,240,982.63-
  资产减值准备3,178,620.46-2,661,266.95-
  固定资产和投资性房地产折旧24,447,826.14-53,355,065.6-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧24,447,826.14-53,355,065.6-
  无形资产摊销2,136,935.65-4,273,964.87-
  长期待摊费用摊销1,021,958.47-1,902,161.65-
  处置固定资产、无形资产和其他长期资产的损失-6,663.05-59,174.03-
  固定资产报废损失6,749.8-143,899.02-
  财务费用15,078,522.87-39,366,353.31-
  投资损失350,293.32-1,312,375.05-
  递延所得税-243,398.68--647,375.14-
  其中:递延所得税资产减少-312,702.18--645,612.48-
    递延所得税负债增加69,303.5--1,762.66-
  存货的减少15,480,715.17-33,943,042-
  经营性应收项目的减少-98,242,876.29-9,140,872.41-
  经营性应付项目的增加-55,076,867.62--196,052,077.13-
  现金的期末余额226,334,081.5-266,066,794.14-
  减:现金的期初余额266,066,794.14-353,971,272.78-
  现金及现金等价物的净增加额-39,732,712.64--87,904,478.64-
公告日期2025-08-272025-04-302025-04-152024-10-31
审计意见(境内)标准无保留意见
TOP↑